Date | Time | Source | Headline | Symbol | Company |
02/24/2011 | 5:00AM | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
02/24/2011 | 5:00AM | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
02/24/2011 | 5:00AM | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
02/23/2011 | 3:40PM | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
02/23/2011 | 3:40PM | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
02/23/2011 | 3:39PM | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
02/23/2011 | 3:39PM | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
02/23/2011 | 3:39PM | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
02/23/2011 | 3:39PM | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
02/23/2011 | 3:38PM | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
02/22/2011 | 4:06PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:KG | King Pharmaceuticals, Inc. |
02/18/2011 | 3:09PM | Edgar (US Regulatory) | Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR) | NYSE:KG | King Pharmaceuticals, Inc. |
02/18/2011 | 3:07PM | Edgar (US Regulatory) | Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR) | NYSE:KG | King Pharmaceuticals, Inc. |
02/18/2011 | 3:05PM | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
02/18/2011 | 3:04PM | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
02/18/2011 | 3:04PM | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
02/18/2011 | 3:02PM | Edgar (US Regulatory) | -National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25) | NYSE:KG | King Pharmaceuticals, Inc. |
02/15/2011 | 4:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:KG | King Pharmaceuticals, Inc. |
02/15/2011 | 10:57AM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NYSE:KG | King Pharmaceuticals, Inc. |
02/14/2011 | 6:07PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NYSE:KG | King Pharmaceuticals, Inc. |
02/14/2011 | 12:52PM | Edgar (US Regulatory) | Schedule 13G | NYSE:KG | King Pharmaceuticals, Inc. |
02/10/2011 | 1:36PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NYSE:KG | King Pharmaceuticals, Inc. |
02/10/2011 | 5:08AM | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NYSE:KG | King Pharmaceuticals, Inc. |
02/09/2011 | 5:08PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
02/09/2011 | 5:07PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
02/09/2011 | 5:07PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
02/09/2011 | 5:06PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
02/09/2011 | 5:06PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
02/09/2011 | 5:04PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
02/08/2011 | 8:34AM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:KG | King Pharmaceuticals, Inc. |